Lyell Immunopharma, Inc. (LYEL)
24.01
+0.31
(+1.31%)
USD |
NASDAQ |
Apr 17, 16:00
23.95
-0.06
(-0.25%)
After-Hours: 20:00
Lyell Immunopharma EPS Diluted (Quarterly) : -6.622 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | -0.1976 |
| Oramed Pharmaceuticals, Inc. | 0.2274 |
| Climb Bio, Inc. | -0.26 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -140.72M |
| Revenue (Quarterly) | 0.006M |
| Total Expenses (Quarterly) | 140.73M |
| Enterprise Value | 159.32M |
| Gross Profit Margin (Quarterly) | -39.85K% |
| Profit Margin (Quarterly) | -2.35M% |
| Earnings Yield | -49.19% |
| Normalized Earnings Yield | -43.00 |